Loading...
XSTO
DIGN
Market cap20mUSD
Jun 05, Last price  
2.42SEK
1D
10.50%
1Q
128.30%
Jan 2017
-80.96%
IPO
-34.00%
Name

Dignitana AB

Chart & Performance

D1W1MN
P/E
—
P/S
2.17
EPS
—
Div Yield, %
—
Shrs. gr., 5y
9.28%
Rev. gr., 5y
17.16%
Revenues
90m
+4.38%
2,104,0001,721,0003,943,0005,528,0008,969,00010,097,00020,334,0004,749,0008,902,00022,941,00033,742,00040,699,00046,630,00057,073,00072,995,00086,063,00089,830,000
Net income
-19m
L+10.46%
-13,725,000-10,774,000-21,556,000-3,664,000-13,230,000-16,560,000-10,914,000-16,569,000-32,269,000-42,600,000-26,021,000-38,035,000-54,928,000-43,086,000-22,411,000-17,363,000-19,179,000
CFO
373k
P
1,573,000-14,438,000-15,958,000-8,883,000-11,869,000-16,313,000-2,930,000-21,421,000-30,605,000-33,467,000-20,632,000-27,334,000-21,303,000-43,873,000-18,164,000-5,744,000373,000
Earnings
Aug 20, 2025

Profile

Dignitana AB (publ), a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. The company was incorporated in 2007 is headquartered in Lund, Sweden.
URL
https://dignitana.com/
IPO date
Jun 18, 2009
Employees
27
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
89,830
4.38%
86,063
17.90%
72,995
27.90%
Cost of revenue
29,555
27,092
26,618
Unusual Expense (Income)
NOPBT
60,275
58,971
46,377
NOPBT Margin
67.10%
68.52%
63.53%
Operating Taxes
37
135
15
Tax Rate
0.06%
0.23%
0.03%
NOPAT
60,238
58,836
46,362
Net income
(19,179)
10.46%
(17,363)
-22.52%
(22,411)
-47.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
13,564
684
23,715
BB yield
-18.26%
-0.45%
-6.99%
Debt
Debt current
7,276
13,027
9,653
Long-term debt
6,077
8,614
Deferred revenue
Other long-term liabilities
3,299
409
187
Net debt
4,322
12,668
9,223
Cash flow
Cash from operating activities
373
(5,744)
(18,164)
CAPEX
(4,451)
(4,597)
(3,221)
Cash from investing activities
(4,504)
(3,796)
(3,130)
Cash from financing activities
1,092
7,039
15,030
FCF
65,914
65,979
49,484
Balance
Cash
2,954
6,027
8,869
Long term investments
409
175
Excess cash
2,133
5,394
Stockholders' equity
(256,711)
(239,286)
7,047
Invested Capital
274,400
266,063
37,310
ROIC
22.29%
38.79%
108.26%
ROCE
340.75%
220.23%
108.60%
EV
Common stock shares outstanding
77,764
69,452
66,130
Price
0.96
-56.19%
2.18
-57.50%
5.13
-41.44%
Market cap
74,264
-50.95%
151,405
-55.37%
339,248
-40.47%
EV
78,586
164,073
805,797
EBITDA
60,275
74,083
60,176
EV/EBITDA
1.30
2.21
13.39
Interest
2,571
1,841
1,993
Interest/NOPBT
4.27%
3.12%
4.30%